Advancements in PatientDerived Organoids

​Expanding a Patient-Derived Organoid Biobank for Drug Screening Lunch & Learn

​Advancements in cell culture techniques are enabling patient-derived organoids, three-dimensional in vitro models that more accurately mimic human physiology than traditional cell lines. These organoids support mechanistic drug-response studies and disease progression.

​Explore our expanding organoid biobank, newly added tissue types, and streamlined characterization workflows that promote adoption and reproducibility. In particular, liver organoids retain metabolic activity and respond to drug-induced injuries, making them ideal for drug screening and toxicology studies.

​Presenter: Dr. Carolina Sierra, R&D Scientist and 3D Cell Culture & Organoid Technology Specialist